Search results

In August, Jimmy Carter was diagnosed with melanoma in his liver and brain. These lesions were addressed directly, he was put on Keytruda and now the former president is in remission. But since this new drug costs about $150,000 per year, we ask: Shouldn't we be talking about this?

On Dec. 10, 1990, Connie Chung generated a shock wave of fear over silicone breast implants. The impact of a TV report by the former CBS News reporter was instantaneous and powerful, producing a new low in one-sided, fear-mongering journalism. Yet today, it remains in the pantheon of all false-science reporting ever perpetrated on the American public.

Trained first responders need to stick to interrupted rescue breathing when performing CPR, as opposed to chest compressions only. According to the largest study of its kind, continuous chest compressions did not offer a better chance of survival, when compared to interrupted chest pumping for performing rescue breathing.

Despite improvements in treatment, mortality still remains unacceptably high in patients diagnosed with heart failure (HF). A recent study provides data that show a new drug on the market improves survival by one and a half to two years. It has potential to be the new cornerstone in HF treatment.

A new study in the journal Pediatrics shows that the Back-to-Sleep campaign, designed to reduce Sudden Infant Death Syndrome, is working. And as it turns out, the effort is also producing even more evidence that vaccines are safe.

A recent study says that survival rates for women with Stage IV breast cancer, in which the tumor has spread to lymph nodes to other regions of the body, has improved. Researchers found a significant link between those who received initial treatment with surgery, and improved survival rates.

Obesity is still rising among young adults, despite more than a decade of public awareness campaigns and other efforts to get people to control their weight. And as of recently, women have overtaken men in the obesity department. Researchers now say that being overweight during early adulthood may put one at greater risk of cardiac death.

Gilead researchers say they are unblinding the ongoing drug trial of Zydelig. The reason is that its leukemia drug was working so well, it should be made available to patients in the trial who were receiving standard treatment without the drug.

If you've been tracking efforts to combat the Hepatitis C virus, you know that 2015 has been a year full of advances and hope for the future. First, there was FDA's approval of the treatment Viekira Pax, and recently California researchers have unearthed diagnostic gold with their latest screening process.

A new treatment option for HIV, in the form of an injectable, may be on the horizon. The company ViiV Healthcare has found that its anti-retroviral treatment, or ART, has rates of efficacy comparable to oral multi-drug therapy.

ACSH and ABC News team up to answer questions about supplements on social media.

A recent Huffington Post op-ed by a female MD demanded "the truth" about mammograms, so that women could best help themselves. Well, there's no truth yet: the data continue to be evaluated and medical societies continue to make the best guesses they can. So, women should learn what they can and discuss the options with their physician.

Bariatric surgery is probably the most successful means of reducing body weight (and fatness) in obese people. But Body Mass Index is not necessarily the best predictor of diabetes remission with the stomach surgery, although it has been the main criterion of eligibility for it.

As measured using objective reviews and standardized parameters, a large survey revealed that an astounding 55 percent of doctors are beaten down by their profession, a major increase over the prior three years. It is likely this trend will get worse, and both doctors and patients will suffer.

Dr. Bennet Omalu, a leading authority on concussion research, wrote in a recent op-ed in the New York Times that children should be banned from playing football, and other "high-impact contact sports," until they are educated enough to decide for themselves. But we wonder whether his proposal will actually protect kids, since they need more activity, not less.

Early this month the FDA sent warning letters to five supplement companies, advising them that picamilon, an ingredient they included in some of their products, does not meet the standard for dietary ingredients.

A new report highlights the number of Americans who are candidates for reducing their risk of heart and vascular disease because they have elevated LDL levels. It also reveals how many of them are actually taking lipid-lowering drugs, such as statins. And as it turns out, it's not enough.

Healthcare is increasingly viewed as a consumer-driven service that can be rated similar to hotels. Not only does the literature not support improved health outcomes from online patient reviews of doctors, they can have potentially damaging consequences.

A new study from Chinese researchers found a small, but significant, benefit among smokers trying to quit who have a particular gene variant related to the dopamine reward system. The benefit is not large enough to give any smokers comfort: just don't even start.

The seasonal nature of the flu shot, as well as misinformation about its perceived toxins, have damaged the vaccine's public image and contributed to its perceived ineffectiveness. But as researchers attempt to come up with a long-lasting universal flu vaccine, a new study may have an answer as to why we are failing to develop it.

Say you're a woman having a screening mammogram and the radiologist finds something suspicious. But it turns out to be a so-called "false-positive," and not any type of cancer. So you're off the hook. Right? Maybe not, because a new study says that result might have implications for developing cancer at a later time.

Most people have heard of SAD, or Seasonal Affective Disorder, which is a fancy term for depression that typically has its onset in late fall or early winter a period when the days are getting shorter. A study found that treatments involving exposure to light, as well as taking medication, showed promise in helping sufferers.

Just when we thought the increase in Type-2 diabetes would go unabated, new statistics published by the Centers for Disease Control and Prevention cast a glimmer of hope in what was an otherwise grim trend. The news was so eye-opening, even CDC researchers were surprised.

Rather than taking AIDS medication prophylactically on a daily basis, it's now possible to use it the following day, a practice that still prevents infection quite well. While this is surprisingly good news, there are also downsides to this approach.

Ritalin, a staple for the treatment of ADHD in children, is the subject of a new Cochrane Report questioning its effectiveness. The review, which also contains caveats that somewhat undercut its primary finding, indicates that the widely-used drug may have a better reputation than it deserves.